Skip to main content

Table 1 Characteristics of patients and controls

From: Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4

 

All histologies n=318

Serous subset n=196

Variable

Ovarian cancer N (%)

Normal N (%)

Ovarian cancer N (%)

Normal N (%)

Number of Cases

258

60

176

20

Age

    

Mean

58

56

57

56

Median

57

56

56

57

Range

26-94

33-72

27-91

33-72

Race

    

Caucasian/White

228 (88%)

58 (97%)

158 (90%)

19 (95%)

African American

2 (1%)

0 (0%)

2 (1%)

0 (0%)

Asian/Pacific Islander

0 (0%)

2 (3%)

0 (0%)

1 (5%)

Hispanic/Latino

1 (<1%)

0 (0%)

1 (1%)

0 (0%)

Unknown

27 (10%)

0 (0%)

15 (9%)

0 (0%)

Stage (AJCC)

    

I

78 (30%)

NA

45 (26%)

NA

II

47 (18%)

NA

33 (19%)

NA

III

45 (17%)

NA

67 (38%)

NA

IV

45 (17%)

NA

31 (18%)

NA

Unknown

43 (17%)

NA

0 (0%)

NA

Grade

    

Low (1)

28 (11%)

NA

17 (10%)

NA

High (2–4)

148 (57%)

NA

111 (63%)

NA

Unknown

82 (32%)

NA

48 (27%)

NA

Histology†

    

Serous

215 (83%)

NA

176 (100%)

NA

Endometrioid

22 (9%)

NA

0 (0%)

NA

Mucinous

15 (6%)

NA

0 (0%)

NA

Clear cell

1 (<1%)

NA

0 (0%)

NA

Other‡

5 (2%)

NA

0 (0%)

NA

  1. †Non-serous tumors are all stages I and II.
  2. ‡2 granulosa cell carcinomas, 1 spinocellular carcinoma, 2 undefined.